A Counterargument to Encounter Frequency and Target Achievement: Measurement Variability

Field	Value	Language
dc.contributor.author	Hayen, Andrew
dc.contributor.author	Bell, Katy J.L.
dc.contributor.author	Glasziou, Paul
dc.contributor.author	Irwig, Les
dc.date.accessioned	2021-04-29T06:02:02Z
dc.date.available	2021-04-29T06:02:02Z
dc.date.issued	2012	en
dc.identifier.uri	https://hdl.handle.net/2123/25003
dc.description.abstract	Editorial response to the conclusion of the recent report by Morrison and colleagues that encounter frequency leads to apparent better control of glucose (hemoglobin A1c), blood pressure, and low-density lipoprotein cholesterol in patients with diabetes mellitus.	en
dc.language.iso	en	en
dc.publisher	American Medical Association	en
dc.relation.ispartof	JAMA Internal Medicine	en
dc.rights	Copyright All Rights Reserved	en
dc.subject	cardiology	en
dc.subject	diabetes	en
dc.subject	dyslipidemia	en
dc.subject	hypertension	en
dc.title	A Counterargument to Encounter Frequency and Target Achievement: Measurement Variability	en
dc.type	Article, Letter	en
dc.subject.asrc	1102 Cardiorespiratory Medicine and Haematology	en
dc.subject.asrc	1117 Public Health and Health Services	en
dc.identifier.doi	10.1001/archinternmed.2011.807
usyd.faculty	SeS faculties schools::Faculty of Medicine and Health::Sydney School of Public Health	en
usyd.citation.volume	172	en
usyd.citation.issue	4	en
usyd.citation.spage	374	en
usyd.citation.epage	375	en
workflow.metadata.only	Yes	en

Associated file/s

There are no files associated with this item.